Cargando…
In vivo pharmacokinetic study of remdesivir dry powder for inhalation in hamsters
Remdesivir dry powder for inhalation was previously developed using thin film freezing (TFF). A single-dose 24-h pharmacokinetic study in hamsters demonstrated that pulmonary delivery of TFF remdesivir can achieve plasma remdesivir and GS-441524 levels higher than the reported EC(50)s of both remdes...
Autores principales: | Sahakijpijarn, Sawittree, Moon, Chaeho, Warnken, Zachary N., Maier, Esther Y., DeVore, Jennie E., Christensen, Dale J., Koleng, John J., Williams, Robert O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683664/ https://www.ncbi.nlm.nih.gov/pubmed/34977555 http://dx.doi.org/10.1016/j.ijpx.2021.100073 |
Ejemplares similares
-
Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing
por: Sahakijpijarn, Sawittree, et al.
Publicado: (2020) -
Niclosamide inhalation powder made by thin-film freezing: Multi-dose tolerability and exposure in rats and pharmacokinetics in hamsters
por: Jara, Miguel O., et al.
Publicado: (2021) -
Formulation Composition and Process Affect Counterion for CSP7 Peptide
por: Sahakijpijarn, Sawittree, et al.
Publicado: (2019) -
Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution
por: Jara, Miguel O., et al.
Publicado: (2022) -
Aerosolizable Plasmid DNA Dry Powders Engineered by Thin-film Freezing
por: Xu, Haiyue, et al.
Publicado: (2023)